Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

USC receives $7.5 million for Comprehensive Center of Excellence in Minority Health

In an effort to stem the rise of childhood obesity and related health risks, the University of Southern California (USC) has received a $7.5 million grant to launch a Comprehensive Center of Excellence in Minority Health.

25 Sep 2007

African American and Latino diabetics far less likely to blood sugar under control

Despite decades of advances in diabetes care, African Americans and Latinos are still far less likely than whites to have their blood sugar under control, even with the help of medications, a new nationally representative study finds.

25 Sep 2007

Breath-analysis testing offers potential for blood sugar monitoring in diabetes

Breath-analysis testing may prove to be an effective, non-invasive method for monitoring blood sugar levels in diabetes, according to a University of California, Irvine study.

25 Sep 2007

Dying for a good night's sleep?

If you are one of those who toss and turn every night trying to get a good night's sleep the latest research from Britain will not make you feel any better.

24 Sep 2007

Type 2 diabetes a massive problem!

The global epidemic of Type 2 diabetes is an indicator of serious underlying issues in our society, says a University of Sydney medical expert.

24 Sep 2007

High GI diet's make fatty liver epidemic a very real threat

According to a recent study, following a high Glycemic Index (GI) diet may increase a persons risk of fatty liver disease.

24 Sep 2007

Diets rich in rapidly-digested carbohydrates may cause fatty liver

Diets rich in rapidly-digested carbohydrates not only expand waistlines, but may also cause fatty liver, a condition that can lead to liver failure and death, finds a new study in mice.

21 Sep 2007

ACTOS associated with reduced risk of heart attack and stroke in patients with type 2 diabetes

Results presented at the 43rd Annual Meeting of the European Association for the Study of Diabetes demonstrate the ability of ACTOS (pioglitazone HCl) to reduce the risk of ischemic cardiovascular disease in patients with type 2 diabetes.

20 Sep 2007

Researchers genetically engineering microorganisms, such as E. coli, into tiny, cellular factories

Microorganisms may soon be efficiently and inexpensively producing novel pharmaceutical compounds, such as flavonoids, that fight aging, cancer or obesity, as well as high-value chemicals, as the result of research being conducted by University at Buffalo researchers.

18 Sep 2007

Any kind of exercise helps control diabetes but combo of aerobic and resistance training the best

According to Canadian researchers any kind of exercise is better than none when it comes to controling type-2 diabetes.

18 Sep 2007

Combined aerobic and resistance training best for people with diabetes

In a new randomized controlled trial, both aerobic and resistance exercise improved glycemic/blood sugar control in people with type 2 diabetes.

18 Sep 2007

Effects of modified alternate-day fasting

Researchers report in the October issue of the Journal of Lipid Research that fasting or eating half as much as usual every other day may shrink your fat cells and boost mechanisms that break down fats.

18 Sep 2007

Immune system police recognize good and bad guys in the body

Immune system police are as good at recognizing bad guys, such as bacteria and viruses, as they are our own tissue, researchers say.

17 Sep 2007

New understanding of immune infertility

Most of us have never heard of immune infertility, yet it prevents many prospective parents from conceiving. Immune infertility is one of 80 autoimmune disorders, a group that includes better-known diseases like Multiple Sclerosis and Type 1 Diabetes.

13 Sep 2007

Researchers question safety of Avandia and it's longterm use

Researchers in the U.S. say the long-term use of a medication used in patients with type 2 Diabetes and people with glucose intolerance, increases the risk for heart failure and heart attacks.

12 Sep 2007

Long-term use of rosiglitazone (Avandia) increases heart attack risk by more than 40 percent

An analysis of four studies involving more than 14,000 patients found that long-term use of the diabetes drug rosiglitazone (Avandia) increased the risk of heart attack by 42 percent and doubled the risk of heart failure, according to a new report from researchers at Wake Forest University School of Medicine and colleagues.

12 Sep 2007

Glycemic control medication appears to have favorable effect regarding risk of cardiovascular events

A meta-analysis of previous research suggests that use of pioglitazone, a glycemic control medication for patients with type 2 diabetes, significantly reduces the risk of heart attack, stroke and death, but increases the risk for serious heart failure, according to an article in the September 12 issue of JAMA: The Journal of the American Medical Association.

12 Sep 2007

GlaxoSmithKline responds to Journal of the American Medical Association articles

GlaxoSmithKline believes that conclusions drawn from the most recent meta-analyses published by Drs. Nissen et. al. and Furberg et. al. in the Journal of the American Medical Association do not confirm a difference in the safety profile of Avandia (rosiglitazone) and Actos (pioglitazone).

12 Sep 2007

Diabetes drug Pioglitazone reduces risk of death, heart attack and stroke, but increases risk of heart failure

A drug widely used to treat type 2 diabetes has been found to reduce the risk of death, heart attack (myocardial infarction) or stroke when used alone or in combination with other therapies for diabetes, according to a Cleveland Clinic study.

12 Sep 2007

Mutations in the insulin gene can cause permanent neonatal diabetes

Mutations in the insulin gene can cause permanent neonatal diabetes, an unusual form of diabetes that affects very young children and results in lifelong dependence on insulin injections, report researchers from the University of Chicago and Peninsula University (Exeter, UK) in Sept. 18, 2007, issue of the Proceedings of the National Academy of Sciences, published early online.

11 Sep 2007

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

USC receives $7.5 million for Comprehensive Center of Excellence in Minority Health

African American and Latino diabetics far less likely to blood sugar under control

Breath-analysis testing offers potential for blood sugar monitoring in diabetes

Dying for a good night's sleep?

Type 2 diabetes a massive problem!

High GI diet's make fatty liver epidemic a very real threat

Diets rich in rapidly-digested carbohydrates may cause fatty liver

ACTOS associated with reduced risk of heart attack and stroke in patients with type 2 diabetes

Researchers genetically engineering microorganisms, such as E. coli, into tiny, cellular factories

Any kind of exercise helps control diabetes but combo of aerobic and resistance training the best

Combined aerobic and resistance training best for people with diabetes

Effects of modified alternate-day fasting

Immune system police recognize good and bad guys in the body

New understanding of immune infertility

Researchers question safety of Avandia and it's longterm use

Long-term use of rosiglitazone (Avandia) increases heart attack risk by more than 40 percent

Glycemic control medication appears to have favorable effect regarding risk of cardiovascular events

GlaxoSmithKline responds to Journal of the American Medical Association articles

Diabetes drug Pioglitazone reduces risk of death, heart attack and stroke, but increases risk of heart failure

Mutations in the insulin gene can cause permanent neonatal diabetes

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in